Cite
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea.
MLA
Shih, Yi‐Ru, et al. “Reimbursement Lag of New Drugs Under Taiwan’s National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea.” CTS: Clinical & Translational Science, vol. 13, no. 5, Sept. 2020, pp. 916–22. EBSCOhost, https://doi.org/10.1111/cts.12778.
APA
Shih, Y., Liao, K., Chen, Y., Lin, F., & Hsiao, F. (2020). Reimbursement Lag of New Drugs Under Taiwan’s National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea. CTS: Clinical & Translational Science, 13(5), 916–922. https://doi.org/10.1111/cts.12778
Chicago
Shih, Yi‐Ru, Kai‐Hsin Liao, Yen‐Hui Chen, Fang‐Ju Lin, and Fei‐Yuan Hsiao. 2020. “Reimbursement Lag of New Drugs Under Taiwan’s National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea.” CTS: Clinical & Translational Science 13 (5): 916–22. doi:10.1111/cts.12778.